Navigation Links
Fossils Push Back Bipedalism to 6 Million Years Ago
Date:3/20/2008

First detailed look at Orrorin tugenensis bones proves earliest hominin walked upright, researchers say

THURSDAY, March 20 (HealthDay News) -- Far from being a recent, revolutionary development, the ability to walk upright on two legs began at the dawn of human evolution more than six million years ago, new research confirms.

The first detailed examination of the fossilized thigh bones of a 4-foot tall creature called Orrorin tugenensis supports the notion that this very early member of the hominin family tree was bipedal, anthropologists say.

"Upright walking is one of the very first traits in our lineage to occur. So this finding reinforces that and pushes the date back even farther," said study co-author Brian Richmond, associate professor of anthropology at George Washington University in Washington, D.C.

But the study also suggests that bipedalism changed through succeeding millennia, and that, biomechanically speaking, O. tugenensis probably walked differently than modern humans.

Richmond and a colleague, William Jungers, of Stony Brook University in Stony Brook, N.Y., published their findings in the March 21 issue of Science.

French anthropologists first discovered the six-million-year-old group of fossil thigh bones, hand bones and teeth in Kenya in 2000. O. tugenesis -- about the size of today's chimpanzees -- lived in an era close to the very origins of human evolution.

"It's right in the time period where we think chimpanzees and humans first split from each other -- about 5 to 8 million years ago," Richmond said.

Bipedalism was crucial to human development because it "freed up our hands," Richmond explained. These free forelimbs allowed humans and their ancestors to begin to explore the use of tools, for example. Expanded brain size may also have accompanied (and been encouraged by) bipedalism, anthropologists say.

'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. $2.4 million grant for study of corneal infections associated with contact lenses
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Good luck indeed: 53 million-year-old rabbits foot bones found
4. Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program
5. Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes
6. GSK Charitable Support Valued at $564 Million in 2007
7. Exploring the Aaah ... $1 Million Grant Advances Aquatic Health Research
8. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
9. 10 Million Baby Boomers Face Alzheimers, Report Predicts
10. Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
11. CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fossils Push Back Bipedalism to 6 Million Years Ago
Fossils Push Back Bipedalism to 6 Million Years Ago
(Date:12/1/2009)..., WASHINGTON, Dec. 1 ...soners and 1,538 federal prisoners were HIV positi...atistics (BJS) in the Office of Justice Programs, ...arend 2008, an estimated 5,672 inmates in state an...762 in 2007. In 2007, about 43 per 10,000 prison i...
(Date:12/1/2009)...fy those who would benefit from liver surgery afte... 1 (HealthDay News) -- A CT scan of liver tumors c...predict overall survival after chemotherapy, resea...o cytotoxic chemotherapy has been shown to improve...ancer and to produce better results in patients ha...
(Date:12/1/2009)... Practitioners of any medical, legal ...are breathing a sigh of relief this week with the ... application, released over the holiday weekend, a...ice recordings to do so quickly and seamlessly usi... (PRWEB) December 1, 2009 -- The iPhone App,...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNewswire/ ...l leader in the development and delivery of custom...ical, scientific and academic markets, will be sho...ch, our first-to-market cross-platform search solu...exicon, based on the American Psychological Associ...
(Date:12/1/2009)..., FORT LAUDERDALE, Fla., Dec. 1 Or... enrollment in the randomized clinical trial of th...mbo Stent). ,, A prospective, randomized, multi...on of an ablu M inal sirolimus coat ED bio- ...t up to 20 sites in Asia, Australia, Europe and So...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
...vailable in German . , One of the defining cha...ically prevent programmed cell death (apoptosis), ...iferation of defective cells. In order to do this,...s, since if the levels of IAPs are reduced, tumour...
...n NPAF,s National Legislative Team, Response to Is... , WASHINGTON, Dec. 1 The National Patient Adv...organization dedicated to the mission of creating ...ayson Fowler to Vice President of Federal Legislat...
... your orthopaedic surgeon is the driving force for...Ill., Dec. 1 /PRNewswire-USNewswire/ - - While ma... any musculoskeletal injury may be anxious to get ... the concerns of orthopaedic surgeons and patients...
...ecember 1 Mentice proudly announces,the launch of...ning - the,Mentice VIST 7.7 enhanced training modu...atures such as vital signs, complications, medicat...ike vital signs and complications imply a dynamic ...
...008 -- 11 a.m. news event -- Hall of States, Room ...C 20001 , , WASHINGTON, Dec. 1 The nation,s ...r to outline the current fiscal situation states a...ase the burden of Medicaid costs. As many states f...
...Two individuals associated with Vinson,Hall Retire... the Pearl Harbor,attack, will participate in a co...t the U.S. Navy Memorial in Washington, D.C. One ...ethods and technologies,for serving seniors. , ...
Other Medicine News:Health News:Surprise discovery made in cancer research 2Health News:National Patient Advocate Foundation (NPAF) Announces New Executive Vice President of Federal Legislative Affairs 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 3Health News:Mentice VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level 2Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:Individuals Associated with Vinson Hall Retirement Community, Who Survived Pearl Harbor Attack, to Participate in Navy Memorial Event December 7 2
(Date:12/1/2009)... Dec. 1 At this year,s annual meet...RSNA), Royal Philips Electronics ( PHG, AEX: PHI) ...t of solutions that provides radiologists the abil...workspot to help drive quality and efficiency. Sh...ll also highlight new capabilities for its portfol...
(Date:12/1/2009)...Dec. 1 ADVENTRX Pharmace...hat a new, recently completed preclinical study ha...ity of ANX-514 and Taxotere® (docetaxel). Sh...NX-514 in South Korea, independently conducted the... confirmation of the bioequivalence and comparable...
(Date:12/1/2009)...CITY, Calif., Dec. 1 Codexis, Inc....and the signing of its second agreement this year ...d,s largest generic drug manufacturer. The new ag...oducts. Codexis announced an earlier agreement wi...t, Teva will use Codexis biocatalysis technology f...
Breaking Medicine Technology:Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Codexis Expands Collaboration with Teva 2Cogdell Spencer Inc Declares Quarterly Dividend 48744 1Cogdell Spencer Inc Declares Quarterly Dividend 48744 2Kaiser Permanente Community Benefit Grant Recipient and Health Activist Rosa Soto Featured in Food Inc Documentary Film 48741 1Kaiser Permanente Community Benefit Grant Recipient and Health Activist Rosa Soto Featured in Food Inc Documentary Film 48741 2Kaiser Permanente Community Benefit Grant Recipient and Health Activist Rosa Soto Featured in Food Inc Documentary Film 48741 3DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 1DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 2DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research 12597 3
...ust their function like a radio dial, not an on/of...immune disease may develop,late in life, MEMPHIS,...pital study shows that T cells, the body,s master ...es to govern the cellular,machinery that regulates...ess sophisticated molecular controls that enable t...
...May 12 Arbios Systems, Inc.,(OTC Bulletin Board: ...d,approval from the U.S. Food and Drug Administrat... ("IDE") to begin the pivotal clinical,trial for S...) liver assist,device for blood purification of ac...sease., "We are pleased to have received FDA appr...
Other Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5
Shoulder Subluxation Inhibitor (SSI)
Comfor™ Shoulder Immobilizer - Universal
...s a critical component of pain relief, functional ...en® Lumbosacral Bracing System™ offers t...vide a high degree of immobilization, unparalled c... . . . even if they gain or lose weight. It combin...
Shoulder Immobilizer with Body Strap
Medicine Products: